Voretigene neparvovec

Therapeutic indications

Voretigene neparvovec is indicated for:

Inherited retinal dystrophy caused by confirmed biallelic RPE65 mutations

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 - 65 years old)

Voretigene neparvovec is indicated for the treatment of adult and paediatric patients with vision loss due to inherited retinal dystrophy caused by confirmed biallelic RPE65 mutations and who have sufficient viable retinal cells.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Voretigene neparvovec is contraindicated in the following cases:

Ocular or periocular infection, intraocular inflammation

at least one of
Infection of skin of eyelid and periocular region
Eye infection
Uveitis

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2020: LUXTURNA Concentrate and solvent for solution for injection
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈